377
Views
10
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Radiotherapy for early stage diffuse large B-cell lymphoma with or without double or triple hit genetic alterations

, , , , , , , & show all
Pages 886-893 | Received 22 Mar 2018, Accepted 17 Jul 2018, Published online: 20 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Michael S. Binkley, Susan M. Hiniker, Sheren Younes, Christopher Yoo, Anjali Wignarajah, Michael Jin, H. Henry Guo, Neel K. Gupta, Yasodha Natkunam, Ranjana H. Advani & Richard T. Hoppe. (2021) Stage I–II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy. Leukemia & Lymphoma 62:8, pages 1840-1849.
Read now
Alexander Augustyn, L. Jeffrey Medeiros, Ethan B. Ludmir, Jillian Gunther, Penny Fang, Shaoying Li, Chi Young Ok, Mikaela E. Bankston, Vivek Verma, Dario Pasalic, Sairah Ahmed, Loretta J. Nastoupil, Jason R. Westin, Paolo Strati, Sattva S. Neelapu, Ranjit Nair, Raphael E. Steiner, Swaminathan P. Iyer, Alma Rodriguez, Luis E. Fayad, Christopher R. Flowers, Bouthaina S. Dabaja & Chelsea C. Pinnix. (2021) The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leukemia & Lymphoma 62:6, pages 1361-1369.
Read now
Taha Al-Juhaishi, John Mckay, Ariel Sindel & Victor Yazbeck. (2020) Perspectives on chemotherapy for the management of double-hit lymphoma. Expert Opinion on Pharmacotherapy 21:6, pages 653-661.
Read now
Lin-Rong Li, Liang Wang, Ying-Zhi He & Ken H. Young. (2019) Current perspectives on the treatment of double hit lymphoma. Expert Review of Hematology 12:7, pages 507-514.
Read now

Articles from other publishers (6)

Alexandra E. Rojek & Sonali M. Smith. (2022) Evolution of therapy for limited stage diffuse large B-cell lymphoma. Blood Cancer Journal 12:2.
Crossref
Eric D. Brooks, Penny Fang & Chelsea C. Pinnix. (2021) Salvage radiotherapy for primary refractory and relapsed diffuse large B-Cell lymphoma. The British Journal of Radiology 94:1127.
Crossref
Yi Xia, Silan Huang, Yu Wang, Dexin Lei, Yanlou Wang, Hang Yang, Yan Gao & Panpan Liu. (2021) Prognostication of Primary Tumor Location in Early-Stage Nodal Diffuse Large B-Cell Lymphoma: An Analysis of the SEER Database. Cancers 13:16, pages 3954.
Crossref
Daniel O. Persky, Sonali M. Smith, Michael L. LeBlanc & Jonathan W. Friedberg. (2020) Reply to E. Hawkes et al. Journal of Clinical Oncology 38:35, pages 4222-4223.
Crossref
Daniel O. Persky, Hongli Li, Deborah M. Stephens, Steven I. Park, Nancy L. Bartlett, Lode J. Swinnen, Paul M. Barr, Jerome D. WinegardenIIIIII, Louis S. Constine, Thomas J. Fitzgerald, John P. Leonard, Brad S. Kahl, Michael L. LeBlanc, Joo Y. Song, Richard I. Fisher, Lisa M. Rimsza, Sonali M. Smith, Thomas P. Miller & Jonathan W. Friedberg. (2020) Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001. Journal of Clinical Oncology 38:26, pages 3003-3011.
Crossref
Brandon S. Imber & Joachim Yahalom. (2020) Radiotherapy for Non-Hodgkin Lymphomas. The Cancer Journal 26:3, pages 217-230.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.